In this video, Robert J. Smith, MD, discusses the many treatment options available to patients with atopic dermatitis.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

Doctors report a steady increase in eczema cases among infants across Indian cities. Experts warn that genetics and ...

When somebody's coming in that has a known diagnosis of atopic dermatitis or eczema and things are really revved up still, if ...

The AJMC® Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.

NKTR stock is up around 150% in today’s trading session following the recently announced positive results from its Phase 2b ...

The Food and Drug Administration in February granted fast track designation for rezpegaldesleukin to treat adults and pediatric patients 12 years and up with moderate to severe atopic dermatitis, the ...

Nektar Therapeutics (NASDAQ: NKTR) stock exploded nearly 157% following news that Rezpeg, the company’s experimental ...

Nektar Therapeutics shares doubled in early trading Tuesday after the U.S. biotech firm said it reached its targets in a ...

Certain pain-related pruritus descriptors may independently predict mental health outcomes, sleep disturbance, and QOL reduction in patients with AD.